SCHEMBL6380914

SCHEMBL6380914

COc1nc(-c2ccccc2)cc2cc(C)ccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SQOR Q9Y6N5 5/20 0.58
MEN1 O00255 6/20 0.53
KMT2A Q03164 6/20 0.53
MAPT P10636 3/20 0.53
TSHR P16473 2/20 0.53
ATM Q13315 2/20 0.53
ADORA1 P30542 1/20 0.48
HPGD P15428 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
LMNA P02545 3/20 0.46
KDM4E B2RXH2 7/20 0.45
ALDH1A1 P00352 6/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
HSD17B10 Q99714 3/20 0.44
NPSR1 Q6W5P4 2/20 0.44
RECQL P46063 1/20 0.44
USP2 O75604 1/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8300158 0.84 NPC1 (0.59) SQORMEN1KMT2AMAPTTSHR
SCHEMBL8272283 0.83 SQOR (0.60) SQORMEN1KMT2AMAPTTSHR
SCHEMBL15483493 0.83 SQOR (0.59) SQORMEN1KMT2AMAPTTSHR
SCHEMBL30112639 0.80 KMT2A (0.50) MEN1KMT2AMAPTTSHRATM
SCHEMBL15483442 0.79 ACP1 (0.44) SQORMEN1KMT2AMAPTKDM4E
SCHEMBL13757363 0.79 SMN1; SMN2 (0.55) SQORMEN1KMT2AMAPTTSHR
SCHEMBL18698069 0.79 KDM4E (0.54) MEN1KMT2AMAPTTSHRATM
SCHEMBL13924286 0.77 APP (0.40) SQORMEN1KMT2AMAPTTSHR
SCHEMBL12033114 0.74 SMN1; SMN2 (0.74) MEN1KMT2AMAPTTSHRATM
SCHEMBL13541767 0.74 MAPT (0.60) MEN1KMT2AMAPTATMHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2033654-B1 Process for resolving a mixture of alkyl ester enantiomers using an enzyme BRISTOL MYERS SQUIBB CO (US) 2012-05-16 EP disclosed
EP-2033654-A1 Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus Bristol-Myers Squibb Company (US) 2009-03-11 EP disclosed
EP-1629000-B1 MACROCYCLIC ISOQUINOLINE PEPTIDE INHIBITORS OF HEPATITIS C VIRUS BRISTOL MYERS SQUIBB CO (US) 2009-02-18 EP disclosed